Patents Assigned to Biolinq Incorporated
-
Patent number: 12285271Abstract: Described herein are variations of an analyte monitoring system, including an analyte monitoring device. For example, an analyte monitoring device may include an implantable microneedle array for use in measuring one or more analytes (e.g., glucose), such as in a continuous manner. The microneedle array may include, for example, at least one microneedle including a tapered distal portion having an insulated distal apex, and an electrode on a surface of the tapered distal portion located proximal to the insulated distal apex. At least some of the microneedles may be electrically isolated such that one or more electrodes is individually addressable.Type: GrantFiled: October 24, 2024Date of Patent: April 29, 2025Assignee: Biolinq IncorporatedInventors: Alan Campbell, Sirilak Sattayasamitsathit, Jared Rylan Tangney, Joshua Ray Windmiller, James Patrick McCanna
-
Patent number: 12279888Abstract: Described herein are variations of an analyte monitoring system, including an analyte monitoring device. For example, an analyte monitoring device may include an implantable microneedle array for use in measuring one or more analytes (e.g., glucose), such as in a continuous manner. The microneedle array may include, for example, at least one microneedle including a tapered distal portion having an insulated distal apex, and an electrode on a surface of the tapered distal portion located proximal to the insulated distal apex. At least some of the microneedles may be electrically isolated such that one or more electrodes is individually addressable.Type: GrantFiled: December 1, 2023Date of Patent: April 22, 2025Assignee: Biolinq IncorporatedInventors: Alan Steven Campbell, Joshua Ray Windmiller, Jared Rylan Tangney
-
Patent number: 12109032Abstract: A method for circumscribing an insulating barrier region around a singular conductive microneedle structure or plurality of conductive microneedle structures adhered to a fixed substrate for the purpose of spatially defining a conduit for the routing of an electrical signal from the surface of said microneedle or microneedles to the posterior surface of the substrate is disclosed herein. A microneedle-based electrochemical biosensors structure comprises a substrate, a microneedle biosensor, a primary electrically conductive element, a secondary electrically conductive element and an electrically insulative annular barrier.Type: GrantFiled: March 6, 2018Date of Patent: October 8, 2024Assignee: Biolinq IncorporatedInventors: Joshua Windmiller, James Patrick McCanna, Jared Rylan Tangney
-
Patent number: 12070313Abstract: Aspects of the current subject matter are directed to a sensor assembly of an analyte monitoring device including one or more microneedle arrays. Aspects are directed to components and architecture of a sensor assembly to implement power and processing aspects of a microneedle array-based continuous analyte monitoring device for the detection and measuring of an analyte. A source of a power-on event is determined, and the analyte monitoring device is transitioned to a mode that corresponds to the determined source. When a power-on event is determined to be a valid power-on event, the analyte monitoring device is transition to a mode that corresponds to a type of the valid power-on event.Type: GrantFiled: July 5, 2023Date of Patent: August 27, 2024Assignee: Biolinq IncorporatedInventors: Daniel Alonso-Soski, Anderson Micu, Yan Li, Christopher Griffith, Jennifer Ruth Walters Fuchs
-
Patent number: 12011294Abstract: Described herein are variations of an analyte monitoring system, including an analyte monitoring device. For example, an analyte monitoring device may include an implantable microneedle array for use in measuring one or more analytes (e.g., glucose), such as in a continuous manner. The microneedle array may include, for example, at least one microneedle including a tapered distal portion having an insulated distal apex, and an electrode on a surface of the tapered distal portion located proximal to the insulated distal apex. At least some of the microneedles may be electrically isolated such that one or more electrodes is individually addressable.Type: GrantFiled: December 21, 2022Date of Patent: June 18, 2024Assignee: Biolinq IncorporatedInventors: Alan Campbell, Sirilak Sattayasamitsathit, Jared Rylan Tangney, Thomas Arnold Peyser, Joshua Ray Windmiller
-
Patent number: 11986614Abstract: An applicator for an analyte monitoring device may include an actuatable housing having a body defining a cavity therein and having a distal opening and a side opening. A cuff and a shuttle are received within the cavity and are separately translatable relative to the housing body. A base may removable engage the housing body at the distal opening. The housing body, the cuff, the shuttle, and/or the base may be engaged with one another with one or more releasable coupling features. The base may be removed from an engagement with the housing body, causing the cuff and the shuttle to be aligned and positioned in a configuration in which the analyte monitoring device, held by the shuttle, is ready for insertion into the skin.Type: GrantFiled: April 25, 2023Date of Patent: May 21, 2024Assignee: Biolinq IncorporatedInventors: George Albert Mansfield, III, David Michael Morelock, Mark Christopher Brister, Nathan Thomas Balcom, Joshua David Doan, Joshua Andrew Warner
-
Patent number: 11963796Abstract: A skin-adorned physiological or biochemical sensing device is disclosed herein. The device preferably comprises a first substrate and a second substrate. The first substrate comprises an array of solid microneedles designed to penetrate a biological interface to access a physiological fluid or tissue. Each microneedle is capable of electrical interface with the physiological fluid or tissue. The second substrate comprises integrated circuitry designed to transduce at least one signal produced by an electrophysiological or electrochemical reaction. A sensing device is formed that is capable of interpreting the signal arising from the electrophysiological or electrochemical reaction to ascertain the level of some physiological or biochemical entity.Type: GrantFiled: June 16, 2021Date of Patent: April 23, 2024Assignee: Biolinq IncorporatedInventors: Joshua Windmiller, Jared Rylan Tangney
-
Patent number: 11904127Abstract: An applicator for an analyte monitoring device may include an actuatable housing having a body defining a cavity therein and having a distal opening and a side opening. A cuff and a shuttle are received within the cavity and are separately translatable relative to the housing body. A base may removable engage the housing body at the distal opening. The housing body, the cuff, the shuttle, and/or the base may be engaged with one another with one or more releasable coupling features. The base may be removed from an engagement with the housing body, causing the cuff and the shuttle to be aligned and positioned in a configuration in which the analyte monitoring device, held by the shuttle, is ready for insertion into the skin.Type: GrantFiled: April 25, 2023Date of Patent: February 20, 2024Assignee: Biolinq IncorporatedInventors: George Albert Mansfield, III, David Michael Morelock, Mark Christopher Brister, Nathan Thomas Balcom, Joshua David Doan, Joshua Andrew Warner
-
Patent number: 11872055Abstract: Described herein are variations of an analyte monitoring system, including an analyte monitoring device. For example, an analyte monitoring device may include an implantable microneedle array for use in measuring one or more analytes (e.g., glucose), such as in a continuous manner. The microneedle array may include, for example, at least one microneedle including a tapered distal portion having an insulated distal apex, and an electrode on a surface of the tapered distal portion located proximal to the insulated distal apex. At least some of the microneedles may be electrically isolated such that one or more electrodes is individually addressable.Type: GrantFiled: October 21, 2022Date of Patent: January 16, 2024Assignee: Biolinq IncorporatedInventors: Jared Rylan Tangney, Joshua Ray Windmiller, Richard Chien Yang
-
Patent number: 11857344Abstract: Fault detection and diagnostics for a microneedle array based continuous analyte monitoring device are provided. The electrochemical sensors, including the electrodes of the analyte monitoring device configured for measuring one or more target analytes, may experience various faults during use of the analyte monitoring device. By modeling the sensors as an electrical network, measurements of the electrical network may be correlated with operational parameters of the sensor. The voltage at the counter electrode provides an indication of the resistance or impedance between the working electrode and the counter electrode and is used to identify the occurrence of faults occurring at the continuous analyte monitoring device.Type: GrantFiled: May 6, 2022Date of Patent: January 2, 2024Assignee: Biolinq IncorporatedInventors: Joshua Ray Windmiller, Alan Steven Campbell, Jared Rylan Tangney
-
Patent number: 11672965Abstract: An applicator for an analyte monitoring device may include an actuatable housing having a body defining a cavity therein and having a distal opening and a side opening. A cuff and a shuttle are received within the cavity and are separately translatable relative to the housing body. A base may removable engage the housing body at the distal opening. The housing body, the cuff, the shuttle, and/or the base may be engaged with one another with one or more releasable coupling features. The base may be removed from an engagement with the housing body, causing the cuff and the shuttle to be aligned and positioned in a configuration in which the analyte monitoring device, held by the shuttle, is ready for insertion into the skin.Type: GrantFiled: September 27, 2022Date of Patent: June 13, 2023Assignee: Biolinq IncorporatedInventors: George Albert Mansfield, III, David Michael Morelock, Mark Christopher Brister, Nathan Thomas Balcom, Joshua David Doan, Joshua Andrew Warner
-
Patent number: D996999Type: GrantFiled: November 16, 2021Date of Patent: August 29, 2023Assignee: Biolinq IncorporatedInventor: David Michael Morelock
-
Patent number: D1012744Type: GrantFiled: May 16, 2022Date of Patent: January 30, 2024Assignee: Biolinq IncorporatedInventor: David Michael Morelock
-
Patent number: D1013544Type: GrantFiled: April 29, 2022Date of Patent: February 6, 2024Assignee: Biolinq IncorporatedInventor: David Michael Morelock
-
Patent number: D1033641Type: GrantFiled: December 17, 2021Date of Patent: July 2, 2024Assignee: Biolinq IncorporatedInventor: David Michael Morelock
-
Patent number: D1035004Type: GrantFiled: February 28, 2023Date of Patent: July 9, 2024Assignee: Biolinq IncorporatedInventor: David Michael Morelock
-
Patent number: D1038794Type: GrantFiled: December 7, 2023Date of Patent: August 13, 2024Assignee: Biolinq IncorporatedInventor: David Michael Morelock
-
Patent number: D1051745Type: GrantFiled: April 27, 2023Date of Patent: November 19, 2024Assignee: Biolinq IncorporatedInventor: David Michael Morelock
-
Patent number: D1057153Type: GrantFiled: April 29, 2022Date of Patent: January 7, 2025Assignee: Biolinq IncorporatedInventor: David Michael Morelock
-
Patent number: D1068516Type: GrantFiled: February 28, 2023Date of Patent: April 1, 2025Assignee: Biolinq IncorporatedInventor: David Michael Morelock